Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Significantly different from non‐abdominal obesity/vitamin D sufficiency (p < 0.05).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

At baseline, participants were classified according to AO (non‐abdominal obesity [NAO] and AO) and 25(OH)D status (sufficiency [VDS], insufficiency [VDI], and deficiency [VDD]), creating six groups: NAO/VDS, NAO/VDI, NAO/VDD, AO/VDS, AO/VDI, and AO/VDD.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Does the Combination of Abdominal Obesity and Vitamin D Deficiency Increase the Risk of Death in Individuals Aged 50 or Older? Evidence From the ELSA Study

Study design awaiting verification · Diabetes, Obesity & Metabolism · 2026

Original publication title

Does the Combination of Abdominal Obesity and Vitamin D Deficiency Increase the Risk of Death in Individuals Aged 50 or Older? Evidence From the ELSA Study

Joyce da Silva Milliati; Thaís Barros Pereira da Silva; Roberta de Oliveira Máximo; Mariane Marques Luiz; Sara Souza Lima; Andrew Steptoe; Cesar de Oliveira; Tiago da Silva Alexandre

© 2026 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

AO combined with 25(OH)D deficiency increases mortality risk in older adults. Early identification and management of these conditions could reduce this risk.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Despite the known association between abdominal obesity (AO) and vitamin D deficiency, it remains unclear whether this combination is associated with higher mortality risk. We investigated whether the coexistence of AO and vitamin D deficiency elevates the risk of death.

Source: Aims

Abstract: What methods does the paper describe?

Five thousand, five hundred twenty participants from the ELSA Study, aged ≥ 50 years, were followed for 6 years. AO was defined by waist circumference (> 102 cm for men and > 88 cm for women). Vitamin D levels, measured via serum 25‐hydroxyvitamin D [25(OH)D] concentrations, were categorised as sufficient (≥ 50 nmol/L), insufficient (30 to 50 nmol/L), and deficient (< 30 nmol/L). At baseline, participants were classified according to AO (non‐abdominal obesity [NAO] and AO) and 25(OH)D status (sufficiency [VDS], insufficiency [VDI], and deficiency [VDD]), creating six groups: NAO/VDS, NAO/VDI, NAO/VDD, AO/VDS, AO/VDI, and AO/VDD.

Cox regression models adjusted for sociodemographic, behavioural, and clinical characteristics estimated mortality risk.

Source: Materials and Methods

Abstract: Results

The NAO/VDI and NAO/VDD groups were associated with a 91% (HR = 1.91; 95% CI: 1.37 to 2.66) and 81% higher risk of death (HR = 1.81; 95% CI: 1.25 to 2.62), respectively. The AO/VDS and AO/VDI groups had a 47% (HR = 1.47; 95% CI: 1.02 to 2.14) and 50% higher mortality risk (HR = 1.50; 95% CI: 1.01 to 2.23), respectively, compared to the NAO/VDS group. The highest mortality risk was observed in the AO/VDD group (HR = 2.23; 95% CI: 1.50 to 3.33).

Source: Results

Abstract: Conclusions

AO combined with 25(OH)D deficiency increases mortality risk in older adults. Early identification and management of these conditions could reduce this risk.

Source: Conclusions
Authors’ abstract

ABSTRACT

Aims

Despite the known association between abdominal obesity (AO) and vitamin D deficiency, it remains unclear whether this combination is associated with higher mortality risk. We investigated whether the coexistence of AO and vitamin D deficiency elevates the risk of death.

Materials and Methods

Five thousand, five hundred twenty participants from the ELSA Study, aged ≥ 50 years, were followed for 6 years. AO was defined by waist circumference (> 102 cm for men and > 88 cm for women). Vitamin D levels, measured via serum 25‐hydroxyvitamin D [25(OH)D] concentrations, were categorised as sufficient (≥ 50 nmol/L), insufficient (30 to 50 nmol/L), and deficient (< 30 nmol/L). At baseline, participants were classified according to AO (non‐abdominal obesity [NAO] and AO) and 25(OH)D status (sufficiency [VDS], insufficiency [VDI], and deficiency [VDD]), creating six groups: NAO/VDS, NAO/VDI, NAO/VDD, AO/VDS, AO/VDI, and AO/VDD.

Cox regression models adjusted for sociodemographic, behavioural, and clinical characteristics estimated mortality risk.

Results

The NAO/VDI and NAO/VDD groups were associated with a 91% (HR = 1.91; 95% CI: 1.37 to 2.66) and 81% higher risk of death (HR = 1.81; 95% CI: 1.25 to 2.62), respectively. The AO/VDS and AO/VDI groups had a 47% (HR = 1.47; 95% CI: 1.02 to 2.14) and 50% higher mortality risk (HR = 1.50; 95% CI: 1.01 to 2.23), respectively, compared to the NAO/VDS group. The highest mortality risk was observed in the AO/VDD group (HR = 2.23; 95% CI: 1.50 to 3.33).

Conclusions

AO combined with 25(OH)D deficiency increases mortality risk in older adults. Early identification and management of these conditions could reduce this risk.

Publication and source details

Original title: Does the Combination of Abdominal Obesity and Vitamin D Deficiency Increase the Risk of Death in Individuals Aged 50 or Older? Evidence From the ELSA Study

Joyce da Silva Milliati; Thaís Barros Pereira da Silva; Roberta de Oliveira Máximo; Mariane Marques Luiz; Sara Souza Lima; Andrew Steptoe; Cesar de Oliveira; Tiago da Silva Alexandre

Diabetes, Obesity & Metabolism · 2026

* Correspondence:
Tiago da Silva Alexandre (tiagoalexandre@ufscar.br)
© 2026 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Conselho Nacional de Desenvolvimento Científico e Tecnológico10.13039/501100003593 305338/2023‐4 Fundação de Amparo à Pesquisa do Estado de São Paulo10.13039/501100001807 2024/01918‐6 Economic and Social Research Council10.13039/501100000269 ES/T008822/11 National Institute for Health Research (NIHR)10.13039/501100000272 98_1074_03 National Institute on Aging10.13039/100000049 R01AG017644

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:38:21.483087+00:00

DOI: 10.1111/dom.70839 · PMC13341344